Trials / Unknown
UnknownNCT05208372
Detection of CTC and ctDNA in the Diagnosis of Metastasis in Gastric Cancer
Application of the Detection of Circulating Tumor Cell and Circulating Tumor DNA in the Diagnosis of Metastasis in Gastric Cancer
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 200 (estimated)
- Sponsor
- First Hospital of China Medical University · Academic / Other
- Sex
- All
- Age
- 18 Years – 79 Years
- Healthy volunteers
- Not accepted
Summary
To investigate the value of CTCs and ctDNA in the diagnosis of metastasis in ascites/peritoneal flushing fluid and blood; To investigate the influence of laparoscopic CO2 pneumoperitoneum establishment on peritoneal and hematogenous metastasis of advanced gastric cancer; To explore the influence of the number and type of CTCs and ctDNA on metastasis and prognosis.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIAGNOSTIC_TEST | CTC test | Circulating tumor cells test of ascites and blood for patients with gastric cancer. |
| DIAGNOSTIC_TEST | ctDNA test | Circulating tumor DNA test of ascites and blood for patients with gastric cancer. |
Timeline
- Start date
- 2022-01-01
- Primary completion
- 2023-02-01
- Completion
- 2024-01-31
- First posted
- 2022-01-26
- Last updated
- 2022-01-26
Locations
2 sites across 1 country: China
Source: ClinicalTrials.gov record NCT05208372. Inclusion in this directory is not an endorsement.